Overview Related Programs & Services Contact Us
Request an Appointment
Get a Second Opinion
Test
Test

What is lymphoblastic lymphoma?

Lymphoblastic lymphoma is a cancer of immature lymphocytes, cells of the immune system, called lymphoblasts. It is a form of non-Hodgkin lymphoma. Lymphoblastic lymphoma primarily affects children and accounts for about 35 percent of all non-Hodgkin lymphomas in children.

Lymphoblastic lymphoma treatment at Dana-Farber/Boston Children's

Children with lymphoblastic lymphoma are treated at Dana-Farber/Boston Children's through the Lymphoma Program in our Hematologic Malignancies Center. One of the top pediatric cancer centers worldwide, Dana-Farber/Boston Children’s combines the expertise of a premier cancer center — Dana-Farber Cancer Institute — and a world-class children’s hospital — Boston Children’s Hospital — to provide internationally-renowned care for children with cancer.

Read about the types of lymphoblastic lymphoma and care for these conditions.

Practitioners Who Specialize In This Condition (14)

Mark Daniel Fleming, MD, DPhil

Mark Daniel Fleming, MD, DPhil

Pathologist-in-Chief; Hematopathology, Department of Pathology
S. Burt Wolbach Professor of Pathology, Harvard Medical School
View Profile

Cancer and Blood Disorders Center

The Dana-Farber/Boston Children's Cancer and Blood Disorders Center is an integrated pediatric hematology and oncology program through Dana-Farber Cancer Institute and Boston Children’s Hospital.

Call 617-355-8246